Literature DB >> 16061356

Developmental toxicity of domoic acid in zebrafish (Danio rerio).

Jessica A Tiedeken1, John S Ramsdell, Ann F Ramsdell.   

Abstract

Domoic acid (DA) is a rigid analog of the excitatory amino acid glutamate. It is produced by the diatom genus Pseudo-nitzschia and is a potent neurotoxin in both adult and developing animals. We have used zebrafish (Danio rerio) as a model to investigate and characterize the developmental toxicity of DA. Domoic acid was administered by microinjection to fertilized eggs at the 128- to 512-cell stages in concentrations ranging from 0.12 to 17 mg/kg (DA/egg weight). DA reduced hatching success by 40% at 0.4 mg/kg and by more than 50% at doses of 1.2 mg/kg and higher. Fifty percent of embryos treated with 1.2 mg/kg DA showed marked tonic-clonic type convulsions at 2 days post fertilization. Four days post fertilization (dpf), all embryos treated with 4.0 mg/kg DA and higher showed a complete absence of touch response reflexes. Commencing 5 dpf, rapid and constant pectoral fin movements were observed, a response which may be related to the hallmark effect in rodents of stereotypic scratching. These data indicate that zebrafish show symptoms of developmental DA toxicity as well as a similar sensitivity comparable to the effects of DA characterized in laboratory rodents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061356     DOI: 10.1016/j.ntt.2005.06.013

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  18 in total

Review 1.  Domoic acid as a developmental neurotoxin.

Authors:  Lucio G Costa; Gennaro Giordano; Elaine M Faustman
Journal:  Neurotoxicology       Date:  2010-05-13       Impact factor: 4.294

2.  The zebrafish (Danio rerio) embryo as a model system for identification and characterization of developmental toxins from marine and freshwater microalgae.

Authors:  John P Berry; Miroslav Gantar; Patrick D L Gibbs; Michael C Schmale
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2006-08-10       Impact factor: 3.228

3.  Short-term exposure of zebrafish embryos to arecoline leads to retarded growth, motor impairment, and somite muscle fiber changes.

Authors:  Wei-Hau Peng; Yen-Chia Lee; Yat-Pang Chau; Kuo-Shyan Lu; Hsiu-Ni Kung
Journal:  Zebrafish       Date:  2014-12-30       Impact factor: 1.985

4.  Can zebrafish be used as animal model to study Alzheimer's disease?

Authors:  Soraya Santana; Eduardo P Rico; Javier S Burgos
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

Review 5.  Ligands for ionotropic glutamate receptors.

Authors:  Geoffrey T Swanson; Ryuichi Sakai
Journal:  Prog Mol Subcell Biol       Date:  2009

Review 6.  Effects of marine toxins on the reproduction and early stages development of aquatic organisms.

Authors:  Vítor Vasconcelos; Joana Azevedo; Marisa Silva; Vítor Ramos
Journal:  Mar Drugs       Date:  2010-01-19       Impact factor: 5.118

7.  Toxicity of cylindrospermopsin, and other apparent metabolites from Cylindrospermopsis raciborskii and Aphanizomenon ovalisporum, to the zebrafish (Danio rerio) embryo.

Authors:  John P Berry; Patrick D L Gibbs; Michael C Schmale; Martin L Saker
Journal:  Toxicon       Date:  2008-12-06       Impact factor: 3.033

8.  Gene expression profiles in zebrafish brain after acute exposure to domoic acid at symptomatic and asymptomatic doses.

Authors:  Kathi A Lefebvre; Susan C Tilton; Theo K Bammler; Richard P Beyer; Sengkeo Srinouanprachan; Patricia L Stapleton; Federico M Farin; Evan P Gallagher
Journal:  Toxicol Sci       Date:  2008-10-20       Impact factor: 4.849

Review 9.  Zebrafish model systems for developmental neurobehavioral toxicology.

Authors:  Jordan Bailey; Anthony Oliveri; Edward D Levin
Journal:  Birth Defects Res C Embryo Today       Date:  2013-03

Review 10.  Public health risks associated with chronic, low-level domoic acid exposure: A review of the evidence.

Authors:  Rebekah Petroff; Alicia Hendrix; Sara Shum; Kimberly S Grant; Kathi A Lefebvre; Thomas M Burbacher
Journal:  Pharmacol Ther       Date:  2021-04-28       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.